J. Kim

428 total citations
9 papers, 360 citations indexed

About

J. Kim is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, J. Kim has authored 9 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 2 papers in Molecular Biology and 1 paper in Pediatrics, Perinatology and Child Health. Recurrent topics in J. Kim's work include Lung Cancer Treatments and Mutations (3 papers), DNA Repair Mechanisms (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). J. Kim is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), DNA Repair Mechanisms (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). J. Kim collaborates with scholars based in South Korea, United Kingdom and Sweden. J. Kim's co-authors include Kwang‐Hee Bae, Yeon‐Soo Seo, Sung-Ho Bae, Eui‐Kyung Lee, Eun‐Sook Kim, Mats Rosenlund, D. Mark Layton, Odd Terje Brustugun, Simon Ekman and A. Juarez-Garcia and has published in prestigious journals such as Nature, Nucleic Acids Research and Annals of Oncology.

In The Last Decade

J. Kim

9 papers receiving 354 citations

Peers

J. Kim

MB

CR

ONCOL

PS

GENET

Thomas Costelloe United States

Rasika Kalamegham United States

ManTek Yeung Canada

Guido Zagnoli-Vieira United Kingdom

Ryan Janke United States

Patrick Héry France

Allen L. Alcivar United States

Marija Vujcic United States

Sascha Emilie Liberti Denmark

Matthew G. Pence United States

Thomas Costelloe United States

J. Kim

462 ×1.5

MB

56 ×1.2

CR

140 ×3.6

ONCOL

41 ×1.1

PS

29 ×0.8

GENET

Citations per year, relative to J. Kim J. Kim (= 1×) peers Thomas Costelloe

Countries citing papers authored by J. Kim

Since Specialization

Citations

This map shows the geographic impact of J. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Kim more than expected).

Fields of papers citing papers by J. Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Kim. The network helps show where J. Kim may publish in the future.

Co-authorship network of co-authors of J. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of J. Kim. A scholar is included among the top collaborators of J. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Kim. J. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Kim, J., et al.. (2024). Treatment compliance, treatment patterns, and healthcare utilization in epilepsy patients with first add-on antiepileptic drugs: A nationwide cohort study. Heliyon. 10(6). e27770–e27770. 1 indexed citations

2.

Lim, Seungtaek, et al.. (2022). 50P Clinical characteristics, treatment patterns and outcomes of EGFR exon 20 insertion and other EGFR mutations in Korean aNSCLC patients. Annals of Oncology. 33. S56–S56. 1 indexed citations

3.

Kim, J., et al.. (2021). The Effect of the Revised Lease Accounting Standard on Financial Statements and Credit Rating of LCCs. Korean Accounting Journal. 30(2). 341–379. 2 indexed citations

4.

Sørensen, Jens Benn, Simon Ekman, Pia Horvat, et al.. (2018). Initial treatment in patients (pts) diagnosed with non-small cell lung cancer (NSCLC) in Denmark from 2005-2015: The SCAN-LEAF study. Annals of Oncology. 29. viii536–viii537. 2 indexed citations

5.

Ekman, Simon, Maria Planck, Jens Benn Sørensen, et al.. (2018). Treatment patterns in patients (pts) with stage IIIB-IV non-small cell lung cancer (NSCLC) in Sweden: The SCAN-LEAF study. Annals of Oncology. 29. viii537–viii537. 2 indexed citations

6.

Kim, J., Eun‐Sook Kim, & Eui‐Kyung Lee. (2017). Evaluation of the chronic disease management program for appropriateness of medication adherence and persistence in hypertension and type-2 diabetes patients in Korea. Medicine. 96(14). e6577–e6577. 23 indexed citations

7.

Kim, J., et al.. (2016). National reimbursement listing determinants of new cancer drugs: a retrospective analysis of 58 cancer treatment appraisals in 2007–2016 in South Korea. Expert Review of Pharmacoeconomics & Outcomes Research. 17(4). 401–409. 10 indexed citations

8.

Kim, J.. (2005). Contrasting effects of Elg1-RFC and Ctf18-RFC inactivation in the absence of fully functional RFC in fission yeast. Nucleic Acids Research. 33(13). 4078–4089. 22 indexed citations

9.

Bae, Sung-Ho, Kwang‐Hee Bae, J. Kim, & Yeon‐Soo Seo. (2001). RPA governs endonuclease switching during processing of Okazaki fragments in eukaryotes. Nature. 412(6845). 456–461. 297 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact